Navigation Links
NicOx Reports First Quarter 2008 Financial Results
Date:5/14/2008

in these programs are revised periodically, if necessary. The payments received from Pfizer for the funding of the research activities are deferred over a period of 12 months from the date of invoice.

Operating expenses

Consolidated operating expenses were euro 17.5 million for the three months ended March 31, 2008, compared to euro 10.1 million for the three months ended March 31, 2007 (adjusted to reflect the reclassification of the research tax credit subsidies into other income as indicated below), of which 87% was attributable to research and development expenses and 13% to selling and administrative expenses in the first quarter of 2008, compared to 79% and 21% respectively in the first quarter of 2007.

Research and development expenses reached euro 15.1 million during the first quarter of 2008, compared to euro 8 million during the same period in 2007 (including euro 0.5 million allocated to cost of sales in 2008 and euro 0.6 million in 2007). These expenses are primarily due to the costs associated with the phase 3 development of naproxcinod, such as expenses related to contract research organizations and suppliers involved in naproxcinod's clinical development and manufacturing activities. At this time, the cost of sales principally corresponds to the expenses incurred by NicOx in performing research activities under the contracts signed with Pfizer and Merck. On March 31, 2008, the Company employed 92 people in research and development, compared to 72 people on March 31, 2007.

Administrative and selling expenses totaled euro 2.3 million in the first quarter of 2008, compared to euro 2.1 million in the first quarter of 2007. General and administrative expenses were euro 1.5 million during the three months ended March 31, 2008 and were primarily the result of personnel expenses in administrative and financial functions, as well as the remuneration of corporate officers, including stock option, bonus share and warrant attributions
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program
2. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
3. IRIDEX Reports First Quarter 2008 Financial Results
4. Cardiome Reports First Quarter Results
5. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
6. Health Plan Execs Receive Smaller Bonuses as Companies Push Performance-Based Pay, HPW Reports; Hanway Tops Others in Total Compensation
7. TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments
8. Med-Emerg International Inc. reports improved income from continuing operations
9. NxStage Medical Reports First Quarter 2008 Results
10. MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results
11. ULURU Inc. Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Garden City, NY (PRWEB) September 30, 2014 ... , R.N., B.S.N., Clinical Manager Specialist, as a 2014 ... with this prestigious distinction for leadership in clinical care. ... the country, spanning virtually every industry and profession, the ... networking community with over 600,000 members and nearly 300 ...
(Date:9/29/2014)... Park Avenue Dental, a leading ... A. Sherman who has dedicated his career to providing ... announced its inclusion in the Patient Connect 365 dentist ... to private accounts so that they may manage online ... system also allows patients to request appointments, better communicate ...
(Date:9/29/2014)... According to the senior spokesman for Fecbek, the ... and was worn by a man, Ötzi the Iceman. ... the direction of using small ornamental purses—which evolved into ... a leading online supplier of fashion accessories, has released ... are fashionable. , For most men, they do ...
(Date:9/29/2014)... Chicago, IL (PRWEB) September 29, 2014 ... the option to review life insurance quotes from top ... search tool available now presents price exploration options at ... quotations are now presented inside of the formatted consumer ... insurers. The life plans that are offered to review ...
(Date:9/29/2014)... Humility of Mary Health Partners will offer SlimDown, ... and Velma Davis Family YMCA in Boardman and St. Joe’s ... manage their weight by making lifestyle changes with regard to ... to 6:30 p.m. Wednesdays at the YMCA, 2045 McClurg Road, ... the Mall (next to the rear entrance to Sears) beginning ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Sarah Shiermeister, Clinical Manager Specialist at Gentiva Health Services, a 2014 Professional Woman of the Year 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 2Health News:Florida’s Park Avenue Dental Now Part of Intuitive Patient Connect 365 Dentist Search Portal 3Health News:Life Insurance Quotes for Chicago Residents Now Quoted Using New Agency Tool Online 2Health News:Humility of Mary Health Partners Offers SlimDown Classes 2
... those at risk, expert says, , FRIDAY, Aug. 14 (HealthDay ... bones in older men, says a new study. , The ... 65 and older who had their sex hormone levels measured ... with low levels of estradiol or high levels of sex ...
... , , TUSTIN, Calif., Aug. ... company with major operations in China, announced today it has filed ... Exchange Act of 1934, as amended, with the Securities and Exchange ... the second quarter ended June 30, 2009. This filing provides for ...
... , WESTON, Fla., Aug. 14 Kidz-Med, ... Sheets: ASFX), is announcing a change in the distribution channels of ... Recently, the Company has learned of Walgreens, intent to cut many ... including the Kidz-Med Thermofocus. To the Company,s knowledge, this decision is ...
... , , Additional 28 ... WASHINGTON, Aug. 14 Today, Secretary of Veterans Affairs Eric ... other assistance in 28 additional communities across the country where the ... , , "VA is committed to providing ...
... , , EDINA, Minn., Aug. 14 ... Assure blood glucose meter test strips do not use GDH-PQQ (glucose ... blood glucose results in patients who are using certain therapeutic products. ... of products use a glucose-specific enzyme and can, therefore, distinguish between ...
... , , WHITE PLAINS, N.Y., ... Next Generation Nutrition Grants, donating a total of $120,000 to four non-profit ... families. , , (Photo: http://www.newsc ... 7 67 ) , , Through ...
Cached Medicine News:Health News:Sex Hormone Levels Linked to Fractures in Men 2Health News:AMDL Inc. Files Notification of Late Filing for Form 10-Q 2Health News:Child Health and Safety Product Distribution Channel Changes 2Health News:Secretary Shinseki Announces Expansion of Counseling for Combat Veterans 2Health News:ARKRAY Statement Regarding U.S. Food and Drug Administration's Public Health Notification: Potentially Fatal Errors With GDH-PQQ Glucose Monitoring Technology 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 2Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 3Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 4Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 5Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 6Health News:The Dannon Company Awards Fourth Annual 'Dannon Next Generation Nutrition Grants' Supporting Nutrition Education for Children 7
(Date:9/29/2014)... , Sept. 29, 2014 Adaptive ... Next Generation Sequencing to profile the adaptive immune ... Scientific Advisory Board to provide strategic and clinical ... suite of assays in the diagnosis and monitoring ... focus of the SAB will be to support ...
(Date:9/29/2014)... BOSTON , Sept. 29, 2014  Arisaph ... on discovery and development of novel therapies for ... has been awarded a phase II Small Business ... I grant, both from the National Cancer Institute ... II award of $1,066,916 supports research and development ...
(Date:9/29/2014)... TEL-AVIV, Israel , Sept. 29, 2014 /PRNewswire/ ... ) ("Galmed"), a clinical-stage biopharmaceutical company focused on ... medication for the treatment of liver diseases and ... EndoPAT™ devices and accessories from Itamar Medical Ltd. ... company whose technology has been cleared by the ...
Breaking Medicine Technology:Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 2Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 2Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 3Arisaph Pharmaceuticals Awarded Supplemental Phase I And Phase II STTR Grants To Develop Oncology Drug Candidates 4Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 2Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function 3
... Hospira, Inc. (NYSE: HSP ... announced positive results from a Phase I U.S. clinical ... renal (kidney) dysfunction who have anemia. Hospira,s trial met ... and distribution in the body, for Hospira,s EPO and ...
... 6, 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... and Chief Executive Officer, will present at the Rodman ... 2011 at 2:25pm ET at the Waldorf Astoria Hotel ... Pharmaceuticals, Inc. Founded in 2008, Omthera ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
... FH system uses a ... infrastructure operating in ... communication of patient information. ... of up to 640 ...
Spacelabs offers an approach that allows your telemetry and step-down units to configure systems to meet their telemetry requirements. Our modular telemetry system data are integrated into the depart...
ISI Alumi-Hand is the safe, sterile, ready-to-use ,surgical hand immobilizer....
The Tele-Pro WEP-4200 Telemetry System is an 8-Patient Stand Alone System. Offering capabilities such as arrhythmia analysis, trends and full disclosure, the Tele-Pro is a system to help hospitals to...
Medicine Products: